With the curtains closing on another year at BIO-Europe, the attending editorial team is still revelling in the interesting conversations from the conference, as patrons gathered to chat about where the industry will go in 2027 as this year comes to a close.
In this episode of the GlobalData Healthcare Podcast, reporters Jam Bensilum and Annabel Kartal-Allen outline the key takeaways while reporting on the ground at the 2026 BIO-Europe conference, held in Cologne, Germany from 9-11 November.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Specifically, they delve into topics including China’s rising influence, artificial intelligence (AI), Europe’s competitiveness, and the latest developments in emerging therapeutic areas.
Kartal-Allen also chats with Cedric Moreau, partner at prominent European venture capital firm, Sofinnova Partners, about what he thinks will be big in M&A going into 2027, and what impact the US midterms will have on the sector moving forward.
With conference season in full swing, keep an eye out for podcasts covering the key takeaways from big events like the upcoming London Life Sciences week.
In addition, you can find plenty of other episodes, bringing you the latest insights into the wonderful world of pharma, biotech, medtech and clinical trials at this link.
